Health Trials

About this trial

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes

Eligibility criteria

Qualifiers

coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging

Disqualifiers

Subjects who are unwilling or unable to provide informed consent.

Acute coronary syndrome within 12 months before inclusion

Severe chronic heart failure (NYHA IV)

Stroke within 6 months before inclusion

Trial design

Treatments tested in this trial

  • Antiplatelet Drug

Treatment groups

No treatment groups listed

Locations

1
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation121552, Moscow Russia

Sponsors and collaborators

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Lead sponsor

Source ClinicalTrials.gov